Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
artificial heart
MedTech
Artificial heart maker Picard Medical plans to go public
Picard Medical, which owns and operates the implant manufacturer SynCardia, aims to list on the New York Stock Exchange under the ticker PMI.
Conor Hale
Apr 1, 2025 12:30pm
Artificial heart maker SynCardia beamed up by Picard Medical
Sep 30, 2021 11:44am
Artificial heart maker Bivacor lands $22M to begin human trials
May 20, 2021 11:05am
MIT researchers develop 'biorobotic hybrid' to test heart valves
Jan 29, 2020 2:00pm
FDA warns of death risk linked to SynCardia heart pump
Aug 22, 2018 10:55am
